Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 937 of 1,261
  1. US 8101643

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  2. US 8101158

    Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  3. US 8101172

    Solenopsis invicta virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  4. US 8101159

    In vivo methods of identifying compounds which target suppressed cancer cells

    The Board of Regents of the University of Oklahoma · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  5. US 8101745

    Lung-targeted drugs

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  6. US 8101724

    High-affinity human antibodies to human protease-activated receptor-2

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  7. US 8101637

    Alkynyl derivatives as modulators of metatropic glutamate receptors

    Addex Pharma, S.A. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  8. US 8101174

    Pharmaceutical compositions for treating arthritis and inflammatory disease

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  9. US 8101627

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  10. US 8101370

    Genes from the 20q13 amplicon and their uses

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  11. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  12. US 8101575

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  13. US 8097701

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  14. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  15. US 8097636

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  16. US 8097695

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  17. US 8097737

    Process for production of optically active amine derivatives

    Takeda Pharmaceutical Company Limited · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  18. US 8097759

    Inflammatory cytokine release inhibitor

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  19. US 8097610

    Derivative having PPAR agonistic activity

    Institute of Medicinal Molecular Design, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  20. US 8097713

    Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  21. US 8097455

    System and method for forming skeletal muscle constructs having functional tissue interfaces

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  22. US 8097606

    Antiglucocorticoids for the treatment of catatonia

    Corcept Therapeutics Incorporated · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  23. US 8097612

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  24. US 8093343

    Nitric oxide-releasing diazeniumdiolated compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.